NEW YORK and SALT LAKE CITY, March 30, 2022 (GLOBE NEWSWIRE) — Renalytix Plc (NASDAQ:RNLX) (LSE: RENX) today announced that, following the Company's announcement on February 22, 2022, Timothy Scannell has been appointed to the Board as an independent Non-Executive Director of Renalytix.
As an accomplished leader in healthcare innovation, Mr. Scannell brings more than 30 years of experience in medical technology to the Renalytix Board, and previously served as President and C.O.O. of Stryker. Mr. Scannell currently serves as Chair of Insulet Corporation's board of directors and serves on the board of directors for Novocure and Collagen Matrix. He holds Bachelor of Business Administration and Master of Business Administration degrees from the University of Notre Dame.
For further information, please contact:
| Renalytix plc | www.renalytix.com |
| James McCullough, CEO | Via Walbrook PR |
| Stifel (Nominated Adviser, Joint Broker) | Tel: 020 7710 7600 |
| Alex Price / Nicholas Moore | |
| Investec Bank plc (Joint Broker) | Tel: 020 7597 4000 |
| Gary Clarence / Daniel Adams | |
| Walbrook PR Limited | Tel: 020 7933 8780 or renalytix@walbrookpr.com |
| Paul McManus / Lianne Applegarth / Alice Woodings | Mob: 07980 541 893 / 07584 391 303 / 07407 804 654 |
| CapComm Partners | Tel: 415-389-6400 or investors@renalytix.com |
| Peter DeNardo |
AIM Rule Regulatory Disclosures
In accordance with Schedule 2(g) of the AIM Rules, Timothy (Tim) John Scannell (aged 57) holds or has held in the past 5 years the following directorships and partnerships:
| Current | Past 5 years |
| Insulet Corporation | Berchtold Corporation |
| Novocure Inc. | CerSys Inc. |
| Collagen Matrix, Inc. | Charger Holding Corp. |
| Gilmartin Fund I L.P. | Concentric Medical, Inc. |
| Entellus Intermediate Sub, Inc. | |
| Everest Biomedical Instruments Company | |
| Explorer Merger Sub Corp. | |
| Fulcrom, Corp. | |
| HeartSine Technologies, LLC | |
| Hit Acquisition Corporation | |
| Hygia Health Services, Inc. | |
| Image Guided Technologies, Inc. | |
| Infinity MSD Corp. | |
| Infinity … |
Full story available on Benzinga.com
